VetDC (Fort Collins) won the 2012 Venture Showcase competition at the 2012 BioWest Conference and Expo at the Marriott City Center Denver, receiving the 7,500 cash prize.
View the YouTube of VetDC Pres/CEO Steven Roy's winning presentation:
VetDC is an emergent veterinary biotechnology company that licenses innovative human biomedical technologies to address serious medical needs in companion animals. By aligning with CSU's top-ranked veterinary school, VetDC has unique capabilities to develop animal therapies, resulting in speed to market, risk reduction, and capital preservation. VetDC has assembled a proven team with regulatory, CMC, and clinical expertise. VetDC's lead candidate, VDC-1101, is an anti-cancer drug with extensive animal data. VDC-1101 is expected to launch in 2014 with $50M peak revenue potential. In 2011, VetDC secured funding from the Colorado Institute for Drug, Device and Diagnostic Development (CID4). VetDC President/CEO Steven Roy made the presentation at the Venture Showcase. For more information, visit: http://www.vet-dc.com.
'The Venture showcase announcement is the capstone to the BioWest Conference,' Giles explains. 'It creates a huge buzz in the industry for the up-and-coming companies chosen to compete. We are very proud to announce VetDC as this year's winner.'"
Link to the Business Wire release
Link to the PitchEngine Social Media Release